GBA1 and Gaucher disease: While Gaucher disease diagnosis is confirmed by demonstrating glucocerebrosidase deficiency in leukocytes, the broad clinical spectrum, including the potential for later-onset neurological complications like Parkinsonism in Type 1, can still delay timely identification [31,32,33,39].